UBS Group AG - AGILE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
UBS Group AG ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$12,000
+500.0%
56,034
+1109.2%
0.00%
Q4 2021$2,0004,634
+509.7%
0.00%
Q3 2021$0
-100.0%
760
+52.0%
0.00%
Q2 2021$1,000
-96.4%
500
-96.3%
0.00%
Q1 2021$28,000
-33.3%
13,376
-9.1%
0.00%
Q4 2020$42,000
+1300.0%
14,720
+1671.4%
0.00%
Q3 2020$3,000
-95.1%
831
-96.3%
0.00%
Q2 2020$61,000
+408.3%
22,197
+350.2%
0.00%
Q4 2019$12,000
+33.3%
4,931
-15.8%
0.00%
Q2 2019$9,0000.0%5,858
+0.9%
0.00%
Q1 2019$9,000
+28.6%
5,806
-50.1%
0.00%
Q4 2018$7,000
+600.0%
11,635
+286.5%
0.00%
Q2 2018$1,000
-90.0%
3,010
-24.8%
0.00%
Q1 2018$10,000
+150.0%
4,000
+300.0%
0.00%
Q3 2017$4,000
-50.0%
1,000
-55.5%
0.00%
Q2 2017$8,000
+700.0%
2,246
+648.7%
0.00%
Q1 2017$1,000
-94.1%
300
-90.1%
0.00%
Q4 2016$17,000
+240.0%
3,018
+302.4%
0.00%
Q3 2016$5,000
+66.7%
750
+66.7%
0.00%
Q2 2016$3,000
-50.0%
450
-53.1%
0.00%
Q1 2016$6,000
-84.6%
959
-76.3%
0.00%
Q4 2015$39,000
+105.3%
4,042
+46.0%
0.00%
Q3 2015$19,0000.0%2,769
+25.8%
0.00%
Q2 2015$19,000
+18.8%
2,201
+24.6%
0.00%
Q1 2015$16,000
+433.3%
1,767
+292.7%
0.00%
Q4 2014$3,0004500.00%
Other shareholders

There were no reported owners of AGILE THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of AGILE THERAPEUTICS INC shareholders